Review article<br>Diabetic nehpropathy and cardiovascular risk

Ewa Żukowska-Szczechowska; Grzegorz Wystrychowski

eISSN: 2084-9877
ISSN: 1896-9666

Przegląd Kardiodiabetologiczny/Cardio-Diabetological Review

Current issue Archive About the journal Contact Instructions for authors

4/2007
vol. 2

Send email

Copy url:

abstract:

Review article
Diabetic nehpropathy and cardiovascular risk

Ewa Żukowska-Szczechowska

,

Grzegorz Wystrychowski

Przegląd Kardiodiabetologiczny 2007; 2, 4: 209–213

Online publish date: 2007/12/21

View full text Get citation

Diabetic nephropathy is associated with increased risk of cardiovascular complications, being part and indicator of generalized microangiopathy. Progress in the knowledge of pathogenesis of vascular complications in diabetes opens new therapeutic and prophylactic options in this clinical condition. Hope for an improved result of the confrontation with diabetes is raised by enrichment of capabilities of renin-angiotensin-aldosterone blockade with eplerenone – selective aldosterone receptor inhibitor, and studies on prevention of vasculopathy on cellular level – through inhibition of protein kinase C b-isoform (ruboxistaurin), breaking cross-links in advanced glycoxidation end-products (alagebrium), and inhibition of histone deacetylase (trichostatin A).

keywords:

Review articleDiabetic nehpropathy and cardiovascular risk

Ewa Żukowska-Szczechowska , Grzegorz Wystrychowski

diabetic nephropathy, microalbuminuria, cardiovascular risk

Review article
Diabetic nehpropathy and cardiovascular risk

Ewa Żukowska-Szczechowska

,

Grzegorz Wystrychowski